The Microbiome Mavericks: How These Startups Are Rewriting the Rules of Medicine and Health.
Industrial Scale Microbiome Mining is a New Drug Discovery Toolbox
Unlocking The Secrets Of The Microbial World: The Pioneering Work Of Biosortia
What’s in store for biotech in 2023? Perhaps 2022 will best be remembered in the life science industry for the return of many of the face-to-face events that fell by the wayside during the COVID-19 pandemic.
Biosortia Microbiomics to Present at Biotech Showcase™ 2023 Biosortia’s proven technology obtains nature’s previously inaccessible drug-like small molecules for treatments and cures
The Microbiome Miner Water is the giver of life, but could it be a giver of untold medicines too? Biosortia CEO Ross Youngs believes so
Don’t start big. Start small and continue small, and it will add up to massive. How steady improvement can also be a breakthrough
Human Microbiome Market (4th Edition): Focus on Therapeutics, Diagnostics and Fecal Microbiota Therapy By L Vijay, November 23, 2022. The human microbiome remained a largely unexplored area until 2007 when the Human Microbiome Project (HMP) was initiated. The project was undertaken to understand the concept of core human microbiome and its compatibility with the host